On May 28, MicroPort Robotics-B declined 5.04% in regular trading, trading at 25.24 HKD/share, with trading volume of approximately 54.32 million HKD.

On the news front, Hillhouse Capital entities significantly reduced their holdings in the company, with a single entity selling approximately 20.639 million shares, reflecting sustained institutional selling pressure. Meanwhile, market concerns over parent company MicroPort Medical potentially divesting its robotics business equity to alleviate cash flow constraints continued to weigh on valuation. The company remains in a loss-making stage with a negative price-to-earnings ratio, intensifying risk-averse sentiment among investors in the current high-valuation environment.

Within the Health Care Equipment sector, the overall sector continued to weaken. Among individual stocks, MICROPORT down 5.24%, LIFETECH SCI down 5.52%, ANGELALIGN down 3.18%, DIAGENS-B down 1.16%, AK MEDICAL down 4.62%, with broad sector resonance amplifying the stock's decline.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)